The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study

EuroIntervention 2016;12:30-37. DOI: 10.4244/EIJV12I1A6

1. Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands; 2. National Heart Centre Singapore, Singapore; 3. Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland

Aims: Limited data are currently available on midterm outcomes after implantation of everolimus-eluting bioresorbable vascular scaffolds (BVS) for treatment of acute ST-elevation myocardi

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Contemporary techniques for catheter-based intervention for hypertrophic obstructive cardiomyopathy